Surgical site infection after open lower extremity revascularization associated with doubled rate of major limb amputation.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
10 2022
Historique:
received: 29 09 2020
revised: 07 04 2022
accepted: 13 04 2022
pubmed: 14 6 2022
medline: 28 9 2022
entrez: 13 6 2022
Statut: ppublish

Résumé

Surgical site infection (SSI) after open lower extremity revascularization is a relatively common complication associated with increased hospital stays, graft infection, and in severe cases, graft loss. Although the short-term effects of SSI can be significant, it has not been considered a complication that increases major limb amputation. The purpose of this study was to determine the association of SSI with outcomes in patients undergoing surgical revascularization for peripheral arterial disease. We analyzed nationwide Vascular Quality Initiative (VQI) data from the infrainguinal bypass module from 2003 to 2017. The cohort included adults who underwent open lower extremity bypass for symptomatic peripheral arterial disease and had at least one follow-up record. Weighted Kaplan-Meier curves and Cox proportional hazards regression were used to assess the association between SSI and 1-year mortality and major limb amputation. Inverse-probability of treatment weights were used to account for differences in demographics and patient characteristics and allow for 'adjusted' Kaplan-Meier curves. The analysis included 21,639 patients, and 1155 (5%) had a reported SSI within 30 days of surgery. Patients with SSI were more likely be obese (41% vs 30%), but there were no other clinically relevant differences between demographics, comorbidities, and bypass details. After weighting, patients with SSI were almost twice as likely to undergo major amputation by 6 months (hazard ratio, 1.84; 95% confidence interval, 1.07-3.17). The association with SSI and increased amputation rates persisted at 1 year. The association of SSI on amputation was no different based on preoperative Rutherford class (P = .91). The association between SSI and 1-year mortality rate was not statistically significant (hazard ratio, 1.15; 95% confidence interval, 0.91-1.46). SSI is more common in obese patients, and patients who develop an SSI are observed to have a significantly increased rate of limb amputation after open lower extremity revascularization.

Identifiants

pubmed: 35697308
pii: S0741-5214(22)01618-4
doi: 10.1016/j.jvs.2022.04.040
pmc: PMC9765967
mid: NIHMS1853085
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1014-1020

Subventions

Organisme : Intramural NIH HHS
ID : Z99 MD999999
Pays : United States

Informations de copyright

Copyright © 2022 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Références

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004122
pubmed: 16856029
J Vasc Surg. 2017 May;65(5):1344-1353
pubmed: 28222984
J Vasc Surg. 2006 Apr;43(4):742-751; discussion 751
pubmed: 16616230
J Vasc Surg. 2014 Nov;60(5):1238-1246
pubmed: 24953898
J Vasc Surg. 2020 Mar;71(3):896-904
pubmed: 31471232
Cochrane Database Syst Rev. 2015 Feb 20;(2):CD004985
pubmed: 25927093
J Am Coll Surg. 2009 Apr;208(4):557-61
pubmed: 19476790
Ann Vasc Surg. 2019 Nov;61:34-47
pubmed: 31349054
J Vasc Surg. 2017 Mar;65(3):711-719.e1
pubmed: 27633166
J Vasc Surg. 2013 Mar;57(3):791-5
pubmed: 23312938
N Engl J Med. 2010 Jan 7;362(1):18-26
pubmed: 20054046
J Vasc Surg. 2016 Feb;63(2):414-9
pubmed: 26526055
Surg Infect (Larchmt). 2000 Winter;1(4):257-63
pubmed: 12594881
Lancet. 2005 Dec 3;366(9501):1925-34
pubmed: 16325694
Ann Vasc Surg. 2014 Apr;28(3):596-605
pubmed: 24370499
J Vasc Surg. 2016 Sep;64(3):629-37
pubmed: 27374064

Auteurs

Micah J Pherson (MJ)

Division of Vascular Surgery, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Paula D Strassle (PD)

Division of Vascular Surgery, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Victoria J Aucoin (VJ)

Division of Vascular Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL.

Corey A Kalbaugh (CA)

Department of Public Health Sciences, Clemson University, Clemson, SC.

Katharine L McGinigle (KL)

Division of Vascular Surgery, Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: katharine_mcginigle@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH